Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 605-708-9 | CAS number: 174125-93-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Skin sensitization: in vivo, male Dunkin-Hartley guinea pig, 10 (test group) / 5 (control),Intradermal injection: 0.5% v/v in Alembicol D, Topical application: as supplied v/v in Alembicol D, Challenge application: as supplied and 50% v/v in Alembicol D, OECD 406, GPMT, GLP: Skin sensitizing Cat. 1B
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1995-10-31 - 1995-12-03
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- OECD Guideline for Testing of Chemicals No. 406 "Skin Sensitisation". Adopted 17 July 1992.
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: MAGNUSSON, B. and KLIGMAN, A.M. (1970) Allergic Contact Dermatitis in the Guinea-pig: Identification of contact allergens, Thomas, C.C., Springfield, Illinois, U.S.A.
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- Study was conducted prior to the implementation of REACH and adoption of the LLNA or suitable in vitro methods.
- Specific details on test material used for the study:
- STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: room temperature - Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- male
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: D. Hall, Newchurch, Staffordshire, England.
- Age at study initiation: four to five weeks
- Weight at study initiation: 294 to 327 g on arrival
- Housing: The guinea-pigs were housed in groups of five in suspended metal cages with wire mesh floors.
- Diet (e.g. ad libitum): A vitamin C enriched guinea-pig diet FD2 was provided ad libitum. Hay was given weekly.
- Water (e.g. ad libitum): ad libitum
- Acclimation period: All the guinea-pigs were acclimatised to the experimental environment for six days prior to allocation to the main study.
- Indication of any skin lesions: none stated
ENVIRONMENTAL CONDITIONS
- Temperature (°C): Animal room temperature was maintained at approximately 21 °C.
- Humidity (%): Relative humidity was maintained at 30 - 70 %.
These environmental parameters were recorded daily.
- Air changes (per hr): Air exchange was maintained at approximately 15 air changes per hour.
- Photoperiod (hrs dark / hrs light): Lighting was controlled by means of a time switch to give 12 hours of artificial light (0700 - 1900 hours) in each 24 hours period. - Route:
- intradermal
- Vehicle:
- other: Alembicol D
- Concentration / amount:
- 0.1 ml of 0.5% solution
- Day(s)/duration:
- day 1
- Adequacy of induction:
- highest concentration used causing mild-to-moderate skin irritation and well-tolerated systemically
- Route:
- epicutaneous, occlusive
- Vehicle:
- unchanged (no vehicle)
- Concentration / amount:
- No. 3 paper was saturated with approximately 0.4 ml of 100% test item
- Day(s)/duration:
- six days after intradermal challenge for 48 h
- Adequacy of induction:
- highest technically applicable concentration used
- No.:
- #1
- Route:
- epicutaneous, semiocclusive
- Vehicle:
- other: Alembicol D
- Concentration / amount:
- Whatman No. 3 paper was saturated with approximately 0.2 ml of the test item as supplied and 50% v/v solution
- Day(s)/duration:
- two weeks after the topical induction for 24h
- No. of animals per dose:
- Six animals for the preliminary investigations, ten test and five control animals were used.
- Details on study design:
- RANGE FINDING TESTS:
Preliminary study
The intradermal and topical irritancy of a range of dilutions of the test substance was investigated to identify where possible (a) concentrations of the test substance that would produce irritation suitable for the induction phase of the main study and (b) a maximum non-irritant concentration by the topical route of administration for the challenge phase.
Animals for these investigations were pre-treated with an intradermal injection of Freund's complete adjuvant, 50:50 with water for irrigation (Ph. Eur), approximately two weeks prior to the start of the preliminary investigations.
Selection of concentrations of test substance for the main study: Based on the results of the preliminary investigations, the following concentrations of the test item were selected:
Induction intradermal injection - 0.5% v/v in Alembicol D (A product of coconut oil, supplied by Alembic Products, Saltney, Chester, England): This was the highest practical concentration that caused irritation but did not adversely affect the animals.
Induction topical application - as supplied
Topical challenge - as supplied and 50% v/v in Alembicol D
This was the highest practical concentration that could be dosed topically and did not give rise to irritating effects.
MAIN STUDY
A. INDUCTION EXPOSURE
Induction intradermal injections - test animals
A 40 x 60 mm area of dorsal skin on the scapular region of the guinea-pig was clipped free of hair with electric clippers. Three pairs of intradermal injections were made into a 20 x 40 mm area within the clipped area as shown in Figure 1.
Injectables for the test animals were prepared as follows:
1. Freund's complete adjuvant** was diluted with an equal volume of water for irrigation (Ph.Eur.).
2. Test item, 0.5% v/v in Alembicol D.
3.Test item, 0.5% v/v in a 50 : 50 mixture of Freund's complete adjuvant and Alembicol D.
** Difco Laboratories, Detroit 1, Michigan, U.S.A.
Induction topical application - test animals
The preliminary investigations indicated that the maximum practical concentration of the test substance for topical application (as supplied) did not produce skin irritation. Therefore, six days after the injections, the same 40 x 60 mm interscapular area was clipped and shaved free of hair and the site was pre-treated by gentle rubbing with 0.5 mJ per site of 10% w/w sodium lauryl sulphate in petrolatum. Twenty-four hours later a 20 x 40 mm patch of Whatman No. 3 paper was saturated with approximately 0.4 ml of the test item, as supplied. The patch was placed on the skin of the test animals and covered by a length of impermeable plastic adhesive tape (50 mm width "Blenderm"). This in turn was firmly secured by elastic adhesive bandage (50 mm width "Elastoplast") wound round the torso of the animal and fixed with "Sleek" impervious plastic adhesive tape. The dressing was left in place for 48 hours.
Induction - control animals
During the induction phase, the control animals were treated similarly to the test animals with the exception that the test substance was omitted from the intradermal injections and topical application.
B. CHALLENGE EXPOSURE
Challenge - control and test animals
The control and test animals were challenged topically two weeks after the topical induction application using the test item, as supplied and 50% v/v in Alembicol D.
Hair was removed by clipping and then shaving from an area on the left flank of each guinea-pig. A 20 x 20 mm patch of Whatman No. 3 paper was saturated with approximately 0.2 ml of the test item, as supplied and applied to an anterior site on the flank. The test item, 50% v/v in Alembicol D was applied in a similar manner to a posterior site. The patches were sealed to the flank for 24 hours under strips of "Blenderm" covered by "Elastoplast" wound round the trunk and secured with "Sleek".
Observations were made 24, 48, and 72 h after challenge - Challenge controls:
- yes, animals not induced with the test item
- Positive control substance(s):
- yes
- Remarks:
- The sensitivity of the guinea-pig strain used is checked periodically at the laboratory with hexyl cinnamic aldehyde, a known sensitiser.
- Positive control results:
- In the available summary of 7 studies with the positive control, it induced the following positive responses (No. of animals with reactions / total number of animals): 10/10, 9/10, 10/10, 9/10, 10/10, 10/10, 8/10.
The positive control gave the appropriate results, and the used guinea pig strain showed the required sensitivity. - Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- undiluted & 50%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- undiluted
- No. with + reactions:
- 5
- Total no. in group:
- 10
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 50%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Reading:
- other: 3rd reading
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- undiluted
- No. with + reactions:
- 6
- Total no. in group:
- 10
- Reading:
- other: 3rd reading
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- 50%
- No. with + reactions:
- 1
- Total no. in group:
- 10
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- undiluted & 50%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- only a few incidences of dryness and sloughing of the epidermis
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- undiluted & 50%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- only a few incidences of dryness and sloughing of the epidermis
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- other: 3rd reading
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- undiluted & 50%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- only a few incidences of dryness and sloughing of the epidermis
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- other: reading, No. not specified
- Group:
- positive control
- Dose level:
- induction: 10% intradermal, topical as supplied; challenge: as supplied and 50%
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Remarks on result:
- positive indication of skin sensitisation
- Remarks:
- Results in four studies; in 2 studies, 9/10 animals showed reacions, in one, 8/10 and 1 inconclusive result was revealed
- Interpretation of results:
- Category 1B (indication of skin sensitising potential) based on GHS criteria
- Conclusions:
- The study was conducted under GLP according to OECD TG 406 (guinea pig maximisation test) on the registered substance itself. The method is to be considered scientifically reasonable with no deficiencies. Positive and negative controls gave the appropriate response. Hence, the results can be considered as sufficiently reliable to assess the irritating properties of the test item.
In this study, the test item produced evidence of skin sensitisation (delayed contact hypersensitivity) in five of the ten test animals. One animal gave an inconclusive response and the remaining four animals gave negative responses.
According to Regulation 1272/2008 / 286/2011, Table 3.4.4 Animal test results for sub-category 1B, a substance must be classified as skin sensitizer if in the Guinea pig maximisation test ≥ 30 % to < 60 % of the animals are responding at > 0.1 % to ≤ 1 % intradermal induction dose or ≥ 30 % responding at > 1 % intradermal induction dose. Intradermal induction was 0.5%, and 50% responded. Hence, Bis(O,O-2-ethylhexyl-thiophosphoryl)polysulfide must be regarded as skin sensitizer Cat. 1B. - Executive summary:
This study was performed to assess the skin sensitisation potential of Bis(O,O-2-ethylhexyl-thiophosphoryl)polysulfide using the guinea-pig. The method followed was that described in: OECD Guideline for Testing of Chemicals No. 406 "Skin Sensitisation". Adopted 17 July 1992, and MAGNUSSON, B. and KLIGMAN, A.M. (1970) Allergic Contact Dermatitis in the Guinea-pig: Identification of contact allergens, Thomas, C.C., Springfield, Illinois, U.S.A.
Based on the results of a preliminary study and in compliance with the guideline, the following dose levels were selected:
Intradermal injection: 0.5% v/v in Alembicol D
Topical application: as supplied v/v in Alembicol D
Challenge application: as supplied and 50% v/v in Alembicol D
Ten test and five control guinea-pigs were used in this study.
In this study Bis(O,O-2-ethylhexyl-thiophosphoryl)polysulfide produced evidence of skin sensitisation (delayed contact hypersensitivity) in five of the ten test animals. One animal gave an inconclusive response and the remaining four animals gave negative responses.
Bis(O,O-2-ethylhexyl-thiophosphoryl)polysulfide must be regarded as skin sensitizer Cat. 1B.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
According to Regulation 1272/2008 / 286/2011, Table 3.4.4 Animal test results for sub-category 1B, a substance must be classified as skin sensitizer if in the Guinea pig maximisation test ≥ 30 % to < 60 % of the animals are responding at > 0,1 % to ≤ 1 % intradermal induction dose or ≥ 30 % responding at > 1 % intradermal induction dose. Intradermal induction was 0.5%, and 50% responded. Hence, Bis(O,O-2-ethylhexyl-thiophosphoryl)polysulfide must be regarded as skin sensitizer Cat. 1B.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.